Phenotypic/JJ
and/CC
functional/JJ
studies/NNS
of/IN
leukocytes/NNS
in/IN
human/JJ
endometrium/NN
and/CC
endometriosis/NN
./.

The/DT
aetiology/NN
of/IN
endometriosis/NN
,/,
a/DT
common/JJ
and/CC
disabling/VBG
disorder/NN
,/,
is/VBZ
presently/RB
unknown/JJ
,/,
although/IN
immune/JJ
dysfunction/NN
could/MD
allow/VB
ectopic/JJ
endometrial/JJ
fragments/NNS
to/TO
survive/VB
outside/IN
the/DT
uterine/JJ
cavity/NN
./.
=====
These/DT
studies/NNS
investigate/VBP
the/DT
relationship/NN
between/IN
leukocyte/NN
populations/NNS
,/,
steroid/NN
hormone/NN
receptor/NN
expression/NN
,/,
proliferative/JJ
activity/NN
,/,
bcl-2/NN
expression/NN
and/CC
apoptosis/NN
in/IN
eutopic/JJ
and/CC
ectopic/JJ
endometrium/NN
from/IN
women/NNS
with/IN
endometriosis/NN
or/CC
adenomyosis/NN
at/IN
different/JJ
phases/NNS
of/IN
the/DT
menstrual/JJ
cycle/NN
./.
=====
Significantly/RB
increased/VBN
oestrogen/NN
receptor/NN
expression/NN
,/,
bcl-2/NN
expression/NN
and/CC
numbers/NNS
of/IN
CD8+/JJ
leukocytes/NNS
were/VBD
found/VBN
in/IN
ectopic/JJ
compared/VBN
with/IN
eutopic/JJ
endometrium/NN
in/IN
endometriosis/NN
,/,
and/CC
CD56+/JJ
endometrial/JJ
granulated/JJ
lymphocytes/NNS
(/(
eGLs/NNS
)/)
were/VBD
significantly/RB
reduced/VBN
in/IN
ectopic/JJ
endometrium/NN
./.
=====
Apoptotic/JJ
cells/NNS
were/VBD
rarely/RB
found/VBN
in/IN
control/JJ
and/CC
subject/NN
endometria/NN
./.
=====
In/IN
contrast/NN
with/IN
endometriosis/NN
,/,
adenomyotic/JJ
lesions/NNS
showed/VBD
identical/JJ
steroid/NN
hormone/NN
receptor/NN
expression/NN
,/,
proliferative/JJ
activity/NN
,/,
bcl-2/NN
expression/NN
and/CC
leukocyte/NN
subpopulations/NNS
to/TO
eutopic/JJ
endometrium/NN
,/,
indicating/VBG
different/JJ
aetiologies/NNS
for/IN
these/DT
disorders/NNS
./.
=====
The/DT
unusual/JJ
CD56+/JJ
CD16-/JJ
eGLs/NNS
present/JJ
in/IN
large/JJ
numbers/NNS
in/IN
late/JJ
secretory/JJ
phase/NN
eutopic/JJ
endometrium/NN
were/VBD
highly/RB
purified/VBN
(/(
>/JJR
98/CD
%/NN
)/)
by/IN
immunomagnetic/JJ
separation/NN
./.
=====
Except/IN
for/IN
a/DT
negligible/JJ
cytotoxic/JJ
activity/NN
of/IN
eGLs/NNS
from/IN
early/JJ
proliferative/JJ
samples/NNS
,/,
cytotoxic/JJ
activity/NN
of/IN
eGLs/NNS
from/IN
non-pregnant/JJ
endometrium/NN
during/IN
the/DT
menstrual/JJ
cycle/NN
was/VBD
comparable/JJ
with/IN
those/DT
in/IN
peripheral/JJ
blood/NN
,/,
predominantly/RB
CD56+/JJ
CD16+/JJ
natural/JJ
killer/NN
cells/NNS
./.
=====
eGLs/NNS
from/IN
non-pregnant/JJ
endometrium/NN
and/CC
early/JJ
pregnancy/NN
showed/VBD
a/DT
variable/JJ
proliferative/JJ
response/NN
to/TO
5/CD
and/CC
100/CD
U/ml/NN
interleukin-2/NN
over/IN
48-h/JJ
and/CC
120-h/JJ
time/NN
courses/NNS
./.
=====
eGLs/NNS
are/VBP
evidently/RB
functionally/RB
important/JJ
in/IN
the/DT
eutopic/JJ
endometrium/NN
./.
=====
Their/PRP$
absence/NN
in/IN
endometriotic/JJ
lesions/NNS
together/RB
with/IN
increased/VBN
CD+8/JJ
T-cell/NN
numbers/NNS
and/CC
increased/VBN
oestrogen/NN
receptor/NN
and/CC
bcl-2/NN
expression/NN
may/MD
have/VB
significant/JJ
effects/NNS
on/IN
the/DT
development/NN
and/CC
progression/NN
of/IN
endometriosis/NN
./.